160 related articles for article (PubMed ID: 31865812)
21. Early neurological worsening in patients with Wilson's disease.
Litwin T; Dzieżyc K; Karliński M; Chabik G; Czepiel W; Członkowska A
J Neurol Sci; 2015 Aug; 355(1-2):162-7. PubMed ID: 26071888
[TBL] [Abstract][Full Text] [Related]
22. [Results of the treatment of Wilson's disease with zinc sulfate and d-penicillamine].
Szleper M; Rodo M; Piłkowska E; Członkowska A
Pol Tyg Lek; 1992 May 18-25; 47(20-21):456-8. PubMed ID: 1437767
[TBL] [Abstract][Full Text] [Related]
23. Neurological worsening in Wilson disease - clinical classification and outcome.
Mohr I; Pfeiffenberger J; Eker E; Merle U; Poujois A; Ala A; Weiss KH
J Hepatol; 2023 Aug; 79(2):321-328. PubMed ID: 37116715
[TBL] [Abstract][Full Text] [Related]
24. Gynecological history to diagnosis and pregnancy outcomes in diagnosed Wilson's disease patients under therapy - A bicentric matched-control cohort study.
Roseira J; Lopes R; Silva MJ; Vieira AM; Sampaio M; Calinas F
Rev Esp Enferm Dig; 2022 Apr; 114(4):198-203. PubMed ID: 33393331
[TBL] [Abstract][Full Text] [Related]
25. Observation on the changes of clinical symptoms, blood and brain copper deposition in Wilson disease patients treated with dimercaptosuccinic acid for 2 years.
Zhou XX; Pu XY; Xiao X; Chen DB; Wu C; Li XH; Liang XL
J Clin Neurosci; 2020 Nov; 81():448-454. PubMed ID: 33222961
[TBL] [Abstract][Full Text] [Related]
26. Clinical presentation and treatment of Wilson's disease: a single-centre experience.
Pellecchia MT; Criscuolo C; Longo K; Campanella G; Filla A; Barone P
Eur Neurol; 2003; 50(1):48-52. PubMed ID: 12824712
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature.
Hartard C; Kunze K
Eur Neurol; 1994; 34(6):337-40. PubMed ID: 7851456
[TBL] [Abstract][Full Text] [Related]
28. Dominant psychiatric manifestations in Wilson's disease: a diagnostic and therapeutic challenge!
Srinivas K; Sinha S; Taly AB; Prashanth LK; Arunodaya GR; Janardhana Reddy YC; Khanna S
J Neurol Sci; 2008 Mar; 266(1-2):104-8. PubMed ID: 17904160
[TBL] [Abstract][Full Text] [Related]
29. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
30. Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.
Członkowska A; Tarnacka B; Litwin T; Gajda J; Rodo M
J Neurol; 2005 Jun; 252(6):698-703. PubMed ID: 15742108
[TBL] [Abstract][Full Text] [Related]
31. A case report: Co-occurrence of Wilson disease and oculocutaneous albinism in a Chinese patient.
Rao R; Shu S; Han YZ; Chiu YJ; Han YS
Medicine (Baltimore); 2018 Dec; 97(50):e13744. PubMed ID: 30558096
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.
Czlonkowska A; Gajda J; Rodo M
J Neurol; 1996 Mar; 243(3):269-73. PubMed ID: 8936358
[TBL] [Abstract][Full Text] [Related]
33. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.
Gromadzka G; Karpińska A; Przybyłkowski A; Litwin T; Wierzchowska-Ciok A; Dzieżyc K; Chabik G; Członkowska A
Biometals; 2014 Feb; 27(1):207-15. PubMed ID: 24368744
[TBL] [Abstract][Full Text] [Related]
34. [Pregnancy, labor and early puerperium in a patient with Wilson's disease].
Hlinst'ák K; Borovský M; Hlinst'áková S
Ceska Gynekol; 1999 Jun; 64(3):198-200. PubMed ID: 10568054
[TBL] [Abstract][Full Text] [Related]
35. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
36. Anesthetic management of cesarean delivery for a parturient with Wilson's disease: A case report.
Wan Y; Jiang X; Lin X
Medicine (Baltimore); 2018 May; 97(20):e10454. PubMed ID: 29768321
[TBL] [Abstract][Full Text] [Related]
37. A study of susceptibility-weighted imaging in patients with Wilson disease during the treatment of metal chelator.
Zhou X; Xiao X; Li XH; Qin HL; Pu XY; Chen DB; Wu C; Feng L; Liang XL
J Neurol; 2020 Jun; 267(6):1643-1650. PubMed ID: 32060651
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study].
Li M; Zhang YH; Qin J
Zhonghua Er Ke Za Zhi; 2003 Feb; 41(2):119-22. PubMed ID: 14759316
[TBL] [Abstract][Full Text] [Related]
39. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
40. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
